Back to Journals » Biologics: Targets and Therapy » Volume 14 » default

Biologics: Targets and Therapy


Archive: Volume 14, 2020

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases

Marafini I, Monteleone G

Biologics: Targets and Therapy 2020, 14:47-51

Published Date: 15 June 2020

Galanin Receptors as Drug Target for Novel Antidepressants: Review

Demsie DG, Altaye BM, Weldekidan E, Gebremedhin H, Alema NM, Tefera MM, Bantie AT

Biologics: Targets and Therapy 2020, 14:37-45

Published Date: 21 April 2020

Autophagy Regulates the Stemness of Cervical Cancer Stem Cells [Retraction]

Yang Y, Yu L, Li J, Yuan YH, Wang XL, Yan SR, Li DS, Ding Y

Biologics: Targets and Therapy 2020, 14:35-36

Published Date: 26 March 2020

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study

Cimmino MA, Parodi M, Barbieri F, Bombardieri S, Zampogna G, Iagnocco A, Batticciotto A, Sconfienza LM, Sinigaglia L, De Benedetti F, Atzeni F, Sarzi-Puttini P

Biologics: Targets and Therapy 2020, 14:13-21

Published Date: 11 February 2020

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease

Al Sulais E, AlAmeel T

Biologics: Targets and Therapy 2020, 14:1-11

Published Date: 10 January 2020